Actively Recruiting
Effect of Sequential "Lying-Sitting-Standing" Baduanjin on Cardiopulmonary Function and Quality of Life in Acute Coronary Syndrome Patients with Heart Failure
Led by Xiling Qi · Updated on 2026-05-05
65
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of a sequential "lying-sitting-standing" Baduanjin exercise on patients who have acute coronary syndrome complicated by heart failure. The study aims to compare this intervention with conventional treatment by assessing heart and lung function as well as quality of life. Key measures include echocardiography, NT-proBNP levels, a six-minute walk test, NYHA classification, and the SF-36 health survey, with the goal of improving early cardiac rehabilitation strategies for these patients. Participants will be randomly assigned to either receive standard treatment with routine rehabilitation nursing guidance or to practice the "lying-sitting-standing" sequential Baduanjin exercise. The intervention lasts 12 weeks, during which researchers will monitor several health indicators and functional assessments. This double-blind study compares these two behavioral approaches to determine their impact on cardiopulmonary function and patient well-being. During the 12-week treatment, participants will undergo evaluations including the six-minute walk test, assessment of heart function by echocardiography, measurement of blood markers such as NT-proBNP and C-reactive protein, and quality of life surveys like the SF-36. Additional assessments include flow-mediated vasodilation and activities of daily living scales. These tests will help researchers measure changes in heart function, physical ability, and overall health status throughout the study period.
CONDITIONS
Brief Title
A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with acute coronary syndrome (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction)
- Complicated by heart failure during hospitalization
- Age 85 years or younger
- Muscle strength grade 3 or higher
- No history of mental illness, conscious and able to cooperate independently with the study
- Voluntary participation and signed informed consent form
You will not qualify if you...
- Persistent heart failure symptoms or NYHA class IV despite optimal pharmacological therapy
- Contraindications to cardiac rehabilitation such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability
- Untreated structural heart disease like valvular or congenital heart disease causing heart failure
- Acute phase of severe diseases such as severe infection, deep vein thrombosis, or severe liver or kidney failure
- Disabilities, bone or joint diseases, or neurological disorders preventing participation in Baduanjin exercises
- Life expectancy less than one year
- Participation in other clinical trials currently
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive either standard treatment and routine rehabilitation nursing guidance or the "Lying-Sitting-Standing" Sequential Baduanjin behavioral intervention to improve cardiopulmonary function and quality of life.
Weekly visits for up to 12 weeks
Trial Site Locations
Total: 1 location
1
Second Hospital of Shanxi Medical
Taiyuan, Shanxi, China, 030001
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here